MicroRNA-331-3p inhibits proliferation and metastasis of ovarian cancer by targeting RCC2.
Conclusions: These data indicate that miR-331-3p can inhibit proliferation, migration, and invasion of ovarian cancer cells via directly targeting RCC2. Our study provides potential therapeutic targets for the treatment of ovarian cancer.
PMID: 31749881 [PubMed]
Source: Archives of Medical Science - Category: General Medicine Tags: Arch Med Sci Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | General Medicine | Genetics | Ovarian Cancer | Ovaries | Science | Study